{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antiviral", "Covid-19", "GS-441524", "Isobutyrate", "Nucleoside", "Prodrug", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34450570", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "05"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bmc.2021.116364", "S0968-0896(21)00372-2"], "Journal": {"ISSN": "1464-3391", "JournalIssue": {"Volume": "46", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "15"}}, "Title": "Bioorganic & medicinal chemistry", "ISOAbbreviation": "Bioorg Med Chem"}, "ArticleTitle": "Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2.", "Pagination": {"StartPage": "116364", "MedlinePgn": "116364"}, "Abstract": {"AbstractText": ["The nucleoside metabolite of remdesivir, GS-441524 displays potent anti-SARS-CoV-2 efficacy, and is being evaluated in clinical as an oral antiviral therapeutic for COVID-19. However, this nucleoside has a poor oral bioavailability in non-human primates, which may affect its therapeutic efficacy. Herein, we reported a variety of GS-441524 analogs with modifications on the base or the sugar moiety, as well as some prodrug forms, including five isobutyryl esters, two l-valine esters, and one carbamate. Among the new nucleosides, only the 7-fluoro analog 3c had moderate anti-SARS-CoV-2 activity, and its phosphoramidate prodrug 7 exhibited reduced activity in Vero E6 cells. As for the prodrugs, the 3'-isobutyryl ester 5a, the 5'-isobutyryl ester 5c, and the tri-isobutyryl ester 5g hydrobromide showed excellent oral bioavailabilities (F\u00a0=\u00a071.6%, 86.6% and 98.7%, respectively) in mice, which provided good insight into the pharmacokinetic optimization of GS-441524."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Road 40-1, Urumqi 830011, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China."}], "LastName": "Wei", "ForeName": "Daibao", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Road 40-1, Urumqi 830011, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China."}], "LastName": "Hu", "ForeName": "Tianwen", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei 430071, China."}], "LastName": "Zhang", "ForeName": "Yumin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China."}], "LastName": "Zheng", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China."}], "LastName": "Xue", "ForeName": "Haitao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China."}], "LastName": "Shen", "ForeName": "Jingshan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China. Electronic address: yuanchaoxie@simm.ac.cn."}], "LastName": "Xie", "ForeName": "Yuanchao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Road 40-1, Urumqi 830011, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China. Electronic address: haji@ms.xjb.ac.cn."}], "LastName": "Aisa", "ForeName": "Haji A", "Initials": "HA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem", "NlmUniqueID": "9413298", "ISSNLinking": "0968-0896"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Prodrugs"}, {"RegistryNumber": "1BQK176DT6", "NameOfSubstance": "GS-441524"}, {"RegistryNumber": "K72T3FS567", "NameOfSubstance": "Adenosine"}], "MeshHeadingList": [{"QualifierName": ["analogs & derivatives", "pharmacokinetics", "pharmacology", "toxicity"], "DescriptorName": "Adenosine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacokinetics", "pharmacology", "toxicity"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["chemical synthesis", "pharmacokinetics", "pharmacology", "toxicity"], "DescriptorName": "Prodrugs"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}, {"QualifierName": [], "DescriptorName": "Mice"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "Sanche S., Lin Y.T., Xu C., et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging Infect Dis. 2020;26:1470\u20131477.", "ArticleIdList": ["PMC7323562", "32255761"]}, {"Citation": "Rubin D., Chan-Tack K., Farley J., Sherwat A. FDA approval of remdesivir \u2014 a step in the right direction. N Engl J Med. 2020;383", "ArticleIdList": ["33264539"]}, {"Citation": "Lamb Y.N. Remdesivir: first approval. Drugs. 2020;80:1355\u20131363.", "ArticleIdList": ["PMC7459246", "32870481"]}, {"Citation": "Eastman R.T., Roth J.S., Brimacombe K.R., et al. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent Sci. 2020;6:672\u2013683.", "ArticleIdList": ["PMC7202249", "32483554"]}, {"Citation": "Siegel D., Hui H.C., Doerffler E., et al. Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo2,1-ftriazin-4-amino adenine C-nucleoside (GS-5734) for the treatment of ebola and emerging viruses. J Med Chem. 2017;60:1648\u20131661.", "ArticleIdList": ["28124907"]}, {"Citation": "Mehellou Y., Rattan H.S., Balzarini J. The ProTide prodrug technology: from the concept to the clinic. J Med Chem. 2018;61:2211\u20132226.", "ArticleIdList": ["PMC7075648", "28792763"]}, {"Citation": "Humeniuk R., Mathias A., Cao H., et al. Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects. Clin Transl Sci. 2020;13:896\u2013906.", "ArticleIdList": ["PMC7361781", "32589775"]}, {"Citation": "Cho A., Saunders O.L., Butler T., et al. Synthesis and antiviral activity of a series of 1\u2032-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett. 2012;22:2705\u20132707.", "ArticleIdList": ["PMC7126871", "22446091"]}, {"Citation": "Do N-D-T, Chatterjee A, Gallay P, et al., A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents; 2021.", "ArticleIdList": ["PMC8233549", "34186107"]}, {"Citation": "Li Y., Cao L., Li G., Cong F., Zhang X. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mice models. J Med Chem. 2020", "ArticleIdList": ["33523654"]}, {"Citation": "Shi Y., Shuai L., Wen Z., et al. The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract. Emerg Microbes Infect. 2021;10:481\u2013492.", "ArticleIdList": ["PMC7993387", "33691601"]}, {"Citation": "Draffan A.G., Frey B., Fraser B.H., et al. Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents. Bioorg Med Chem Lett. 2014;24:4984\u20134988.", "ArticleIdList": ["25288185"]}, {"Citation": "Metobo S.E., Xu J., Saunders O.L., et al. Practical synthesis of 1\u2032-substituted Tubercidin C-nucleoside analogs. Tetrahedron Lett. 2012;53:484\u2013486."}, {"Citation": "Kaczmarek O, Brodersen N, Bunge A, et al. Synthesis of nucleosides with 2\u2032-fixed lipid anchors and their behavior in phospholipid membranes. 2008;2008:1917\u201328."}, {"Citation": "Zhu L., dos Santos O., Seeman N.C., Canary J.W. Reaction of N3-benzoyl-3',5'-O-(di-tert-butylsilanediyl)uridine with hindered electrophiles: intermolecular N3 to 2'-O protecting group transfer. Nucleosides Nucleotides Nucleic Acids. 2002;21:723\u2013735.", "ArticleIdList": ["12502286"]}, {"Citation": "Pruijssers A.J., George A.S., Sch\u00e4fer A., et al. Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep. 2020;32:107940. doi: 10.1016/j.celrep.2020.107940.", "ArticleIdList": ["10.1016/j.celrep.2020.107940", "PMC7340027", "32668216"]}, {"Citation": "Zhang L., Zhang D., Wang X.W., et al. 1 '-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication. Phys Chem Chem Phys. 2021;23:5852\u20135863.", "ArticleIdList": ["33688867"]}, {"Citation": "Sheahan T.P., Sims A.C., Zhou S., et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020;12:eabb5883.", "ArticleIdList": ["PMC7164393", "32253226"]}, {"Citation": "Wright N.J., Lee S.-Y. Toward a molecular basis of cellular nucleoside transport in humans. Chem Rev. 2021;121:5336\u20135358.", "ArticleIdList": ["PMC10032034", "33232132"]}, {"Citation": "GS-441524 PK Property Overview. Can be found under https://opendata.ncats.nih.gov/covid19/GS-441524."}, {"Citation": "First-in-Human Study of Orally Administered GS-441524 for COVID-19 can be found under https://clinicaltrials.gov/ct2/show/NCT04859244."}, {"Citation": "Klumpp K., Smith D.B. Discovery and clinical evaluation of the nucleoside analog balapiravir (R1626) for the treatment of HCV infection. Antiviral Drugs. 2011:287\u2013304."}, {"Citation": "Xie Y., Guo X., Hu T., et al. Significant inhibition of porcine epidemic diarrhea virus in vitro by remdesivir, its parent nucleoside and \u03b2-D-N(4)-hydroxycytidine. Virol Sin. 2021;1\u20139", "ArticleIdList": ["PMC7983969", "33751399"]}, {"Citation": "Li Q., Groaz E., Rocha-Pereira J., Neyts J., Herdewijn P. Anti-norovirus activity of C7-modified 4-amino-pyrrolo2,1-f1,2,4triazine C-nucleosides. Eur J Med Chem. 2020;195", "ArticleIdList": ["32294613"]}, {"Citation": "Warren T.K., Jordan R., Lo M.K., et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531:381\u2013385.", "ArticleIdList": ["PMC5551389", "26934220"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "5"}, {"Year": "2021", "Month": "8", "Day": "6"}, {"Year": "2021", "Month": "8", "Day": "7"}, {"Year": "2021", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "27", "Hour": "20", "Minute": "30"}, {"Year": "2021", "Month": "8", "Day": "11"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34450570", "PMC8354861", "10.1016/j.bmc.2021.116364", "S0968-0896(21)00372-2"]}}], "PubmedBookArticle": []}